Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

DXA Precision and Accuracy Comparison Study
DXA Precision and Accuracy Comparison Study
Status: Enrolling
Updated:  11/15/2015
Colorado Center for Bone Research
1018
mi
from 98109
Lakewood, CO
DXA Precision and Accuracy Comparison Study
DXA Precision and Accuracy Comparison Study
Status: Enrolling
Updated: 11/15/2015
Colorado Center for Bone Research
1018
mi
from 98109
Lakewood, CO
Click here to add this to my saved trials
B-Receptor Signaling in Cardiomyopathy
B-Receptor Signaling in Cardiomyopathy
Status: Enrolling
Updated:  11/16/2015
Stanford University School of Medicine
705
mi
from 98109
Stanford, CA
B-Receptor Signaling in Cardiomyopathy
B-Receptor Signaling in Cardiomyopathy
Status: Enrolling
Updated: 11/16/2015
Stanford University School of Medicine
705
mi
from 98109
Stanford, CA
Click here to add this to my saved trials
P400 for Stage II-IV Pressure Ulcers in Home and Extended Care
Assessment of the Incidence and Treatment of Stage II -IV Pressure Ulcers in the Home Care or Extended Care Environments Utilizing the P400 Mattress
Status: Enrolling
Updated:  11/16/2015
Southwest Regional Wound Care Center
1439
mi
from 98109
Lubbock, TX
P400 for Stage II-IV Pressure Ulcers in Home and Extended Care
Assessment of the Incidence and Treatment of Stage II -IV Pressure Ulcers in the Home Care or Extended Care Environments Utilizing the P400 Mattress
Status: Enrolling
Updated: 11/16/2015
Southwest Regional Wound Care Center
1439
mi
from 98109
Lubbock, TX
Click here to add this to my saved trials
A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs
A Prospective, Open, Comparative, Randomized, Single-centre Study to Evaluate the Effect of Cadexomer Iodine Gel (IODOSORB) Compared to Standard Dressings (SOLOSITE) on Biofilm Disruption in Infected Diabetic Foot Ulcers (DFUs)
Status: Enrolling
Updated:  11/16/2015
St. Luke's Roosevelt Hospital
2401
mi
from 98109
New York, NY
A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs
A Prospective, Open, Comparative, Randomized, Single-centre Study to Evaluate the Effect of Cadexomer Iodine Gel (IODOSORB) Compared to Standard Dressings (SOLOSITE) on Biofilm Disruption in Infected Diabetic Foot Ulcers (DFUs)
Status: Enrolling
Updated: 11/16/2015
St. Luke's Roosevelt Hospital
2401
mi
from 98109
New York, NY
Click here to add this to my saved trials
Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis
Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis
Status: Enrolling
Updated:  11/16/2015
Stanford Hospital and Clinics
703
mi
from 98109
Palo Alto, CA
Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis
Feasibility of a Mobile Electronic Mindfulness Therapy Service for Chronic Pancreatitis
Status: Enrolling
Updated: 11/16/2015
Stanford Hospital and Clinics
703
mi
from 98109
Palo Alto, CA
Click here to add this to my saved trials
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
Status: Enrolling
Updated:  11/16/2015
Michael E. Debakey VA Medical Center
1892
mi
from 98109
Houston, TX
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making
Status: Enrolling
Updated: 11/16/2015
Michael E. Debakey VA Medical Center
1892
mi
from 98109
Houston, TX
Click here to add this to my saved trials
Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy
Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy
Status: Enrolling
Updated:  11/17/2015
Baystate Medical Center
2423
mi
from 98109
Springfield, MA
Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy
Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy
Status: Enrolling
Updated: 11/17/2015
Baystate Medical Center
2423
mi
from 98109
Springfield, MA
Click here to add this to my saved trials
A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
A Phase 2a Study of an Anti-LOXL2 Monoclonal Antibody (GS-6624) in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Status: Enrolling
Updated:  11/17/2015
NIH Department of Laboratory Medicine
2316
mi
from 98109
Bethesda, MD
A Phase 2a Study of Simtuzumab in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
A Phase 2a Study of an Anti-LOXL2 Monoclonal Antibody (GS-6624) in HIV and/or Hepatitis C- Infected Subjects With Liver Fibrosis
Status: Enrolling
Updated: 11/17/2015
NIH Department of Laboratory Medicine
2316
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients
Status: Enrolling
Updated:  11/17/2015
Substance Use Research Unit
680
mi
from 98109
San Francisco, CA
Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients
Status: Enrolling
Updated: 11/17/2015
Substance Use Research Unit
680
mi
from 98109
San Francisco, CA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
998
mi
from 98109
Mission Viejo, CA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
998
mi
from 98109
Mission Viejo, CA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
994
mi
from 98109
Newport Beach, CA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
994
mi
from 98109
Newport Beach, CA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2424
mi
from 98109
Bridgeport, CT
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2424
mi
from 98109
Bridgeport, CT
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2603
mi
from 98109
Melbourne, FL
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2603
mi
from 98109
Melbourne, FL
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2545
mi
from 98109
Winter Park, FL
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2545
mi
from 98109
Winter Park, FL
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
1733
mi
from 98109
Chicago, IL
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
1500
mi
from 98109
Kansas City, KA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
1500
mi
from 98109
Kansas City, KA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2478
mi
from 98109
Biddeford, ME
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2478
mi
from 98109
Biddeford, ME
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2485
mi
from 98109
Boston, MA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2485
mi
from 98109
Boston, MA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
1720
mi
from 98109
St Louis, MO
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
1720
mi
from 98109
St Louis, MO
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2438
mi
from 98109
Concord, NH
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2438
mi
from 98109
Concord, NH
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2400
mi
from 98109
New York, NY
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2400
mi
from 98109
New York, NY
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2283
mi
from 98109
Charlotte, NC
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2283
mi
from 98109
Charlotte, NC
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2341
mi
from 98109
Durham, NC
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2341
mi
from 98109
Durham, NC
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
1967
mi
from 98109
Cincinnati, OH
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2006
mi
from 98109
Franklin, OH
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2006
mi
from 98109
Franklin, OH
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
147
mi
from 98109
Portland, OR
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
147
mi
from 98109
Portland, OR
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
1970
mi
from 98109
Nashville, TN
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
1970
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
1682
mi
from 98109
Dallas, TX
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Clinical Research Facility
2
mi
from 98109
Seattle, WA
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Clinical Research Facility
2
mi
from 98109
Seattle, WA
Click here to add this to my saved trials
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated:  11/17/2015
Investigational Site Number 076004
2329
mi
from 98109
São Paulo,
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia
Status: Enrolling
Updated: 11/17/2015
Investigational Site Number 076004
2329
mi
from 98109
São Paulo,
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
UCSD Department of Surgery
1065
mi
from 98109
San Diego, CA
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
UCSD Department of Surgery
1065
mi
from 98109
San Diego, CA
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Indiana University
1866
mi
from 98109
Indianapolis, IN
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Indiana University
1866
mi
from 98109
Indianapolis, IN
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Washington University
1717
mi
from 98109
St. Louis, MO
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Washington University
1717
mi
from 98109
St. Louis, MO
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Greenville Hospital System
2227
mi
from 98109
Greenville, SC
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Greenville Hospital System
2227
mi
from 98109
Greenville, SC
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Vanderbilt University Medical Center
1971
mi
from 98109
Nashville, TN
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Medical College of Wisconsin
1687
mi
from 98109
Milwaukee, WI
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Mount Sinai Medical Center
2402
mi
from 98109
New York City, NY
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Mount Sinai Medical Center
2402
mi
from 98109
New York City, NY
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Case Medical Center, Case Western Reserve University, Case Western Reserve University
2020
mi
from 98109
Cleveland, OH
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Case Medical Center, Case Western Reserve University, Case Western Reserve University
2020
mi
from 98109
Cleveland, OH
Click here to add this to my saved trials
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated:  11/18/2015
Canisius-Wilhelmina Ziekenhuis
4914
mi
from 98109
Nijmegen,
Open Complex Ventral Incisional Hernia Repair Using Biosynthetic Material for Midline Fascial Closure Reinforcement
Prospective, Multicenter, Observational Study Evaluate Single-Staged Open Complex Ventral Incisional Hernia Repair Using a Biosynthetic Material for Midline Fascial Closure Reinforcement
Status: Enrolling
Updated: 11/18/2015
Canisius-Wilhelmina Ziekenhuis
4914
mi
from 98109
Nijmegen,
Click here to add this to my saved trials
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
Tumor Necrosis Factor Alpha Inhibitor (Lnfliximab, Adalimumab) Treatment for Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences
Status: Enrolling
Updated:  11/19/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
Tumor Necrosis Factor Alpha Inhibitor (Lnfliximab, Adalimumab) Treatment for Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease: A Phase I/II Study Assessing Clinical and Immune Responses to Treatment and Genetic Influences
Status: Enrolling
Updated: 11/19/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
2315
mi
from 98109
Bethesda, MD
Click here to add this to my saved trials
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Status: Enrolling
Updated:  11/20/2015
Holtz's Children's Hospital- University of Miami/Jackson Memorial Hospital
2730
mi
from 98109
Miami, FL
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in Infants
Status: Enrolling
Updated: 11/20/2015
Holtz's Children's Hospital- University of Miami/Jackson Memorial Hospital
2730
mi
from 98109
Miami, FL
Click here to add this to my saved trials
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
2544
mi
from 98109
Orlando, FL
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
2544
mi
from 98109
Orlando, FL
Click here to add this to my saved trials
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated:  11/20/2015
Clinical Research Facility
2113
mi
from 98109
Knoxville, TN
A Study of The Effect of Hepatic Impairment on The Pharmacokinetics of Aleglitazar
The Effect of Hepatic Impairment on the Pharmacokinetics of Aleglitazar: A Multiple-centre, Open-label Study Following a Single Oral Dose of Aleglitazar to Subjects With Mild or Moderate Hepatic Impairment and Healthy Subjects With Normal Hepatic Function.
Status: Enrolling
Updated: 11/20/2015
Clinical Research Facility
2113
mi
from 98109
Knoxville, TN
Click here to add this to my saved trials
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Status: Enrolling
Updated:  11/23/2015
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Status: Enrolling
Updated: 11/23/2015
The Mayo Clinic
1450
mi
from 98109
Rochester, MN
Click here to add this to my saved trials
Analgesia in Children Using Caudal Epidural Ropivacaine
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study
Status: Enrolling
Updated:  11/23/2015
Loma Linda University Medical Center
974
mi
from 98109
Loma Linda, CA
Analgesia in Children Using Caudal Epidural Ropivacaine
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study
Status: Enrolling
Updated: 11/23/2015
Loma Linda University Medical Center
974
mi
from 98109
Loma Linda, CA
Click here to add this to my saved trials
Analgesia in Children Using Caudal Epidural Ropivacaine
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study
Status: Enrolling
Updated:  11/23/2015
Loma Linda University Outpatient Surgery Center
975
mi
from 98109
Loma Linda, CA
Analgesia in Children Using Caudal Epidural Ropivacaine
Preemptive Analgesia in Children Using Caudal Epidural Ropivacaine: A Prospective, Randomized, Double-blinded, Controlled Study
Status: Enrolling
Updated: 11/23/2015
Loma Linda University Outpatient Surgery Center
975
mi
from 98109
Loma Linda, CA
Click here to add this to my saved trials
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/23/2015
Institute for Advanced Wound Care
2155
mi
from 98109
Montgomery, AL
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/23/2015
Institute for Advanced Wound Care
2155
mi
from 98109
Montgomery, AL
Click here to add this to my saved trials
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/23/2015
HealthEast Care System, Inc
1399
mi
from 98109
St. Paul, MN
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/23/2015
HealthEast Care System, Inc
1399
mi
from 98109
St. Paul, MN
Click here to add this to my saved trials
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/23/2015
Jobst Vascular Institute
1926
mi
from 98109
Toledo, OH
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/23/2015
Jobst Vascular Institute
1926
mi
from 98109
Toledo, OH
Click here to add this to my saved trials
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/23/2015
Lawson Health Research Institute
1998
mi
from 98109
London,
A Clinical Study to Assess a Compression Device in Patients With Venous Leg Ulcers
A Randomized, Controlled, Clinical Study to Assess a New Adjustable Compression Device in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/23/2015
Lawson Health Research Institute
1998
mi
from 98109
London,
Click here to add this to my saved trials